Proteus penneri bacteremia and concomitant subcutaneous infection developed in a neutropenic patient with acute Iymphocytic leukemia. The skin infection occurred while the patient was being treated empirically with cefoperazone and metronidazole. This case demonstrates the invasive potential of this microorganism in the proper setting.
Documented human clinical infections caused by Proteus penneri have been limited to the urinary tract (3, 6, 7) and to wounds of the abdomen, groin, neck, and ankle (7) . In each of the latter cases, culture of the wound site yielded P. penneri in concert with other gram-negative enteric organisms or gram-positive cocci. In these instances, the true disease-producing potential of this species was difficult to assess. In the present report, however, we describe a patient with leukemia in whom a P. penneri bacteremia and concomitant subcutaneous thigh abscess developed, which demonstrates the invasive potential of this bacterium in the appropriate setting.
Case report. A 59-year-old male with a 3-month history of epistaxis and fatigue was admitted. His complete blood count on admission showed a hemoglobin of 11.7 g/dl, a hematocrit of 31.4%, a leukocyte count of 16,500/mm3 with 6% blast cells, and a platelet count of 21,000/mm3. Examination of a bone marrow aspirate resulted in a diagnosis of acute lymphocytic leukemia. Treatment with daunorubicin, vincristine, and prednisone was begun. On day 10 of treatment, he developed a fever of 38.6°C and was given cefoperazone and metronidazole empirically, after which he became afebrile. On hospital day 16, while still on antibiotics, the patient developed an indurated, tender, erythematous lesion (4 by 3 cm) of the lateral left leg. At that time, he was afebrile, with a neutrophil count of 2,100/mm3. P. penneri was grown in blood culture bottles containing tryptic soy broth with sodium polyethanolesulfonate (Difco Laboratories, Detroit, Mich.) and Thiol broth (Difco) and from a needle aspirate of the skin lesion. Amikacin was added to the antibiotic regimen, and the skin lesion resolved over a period of 7 days. Antibiotics were continued for a total of 14 days following the appearance of the skin lesion.
P. penneri was isolated in pure culture from the blood and skin lesion aspirate of the patient and was identified by standard microbiological methods (4 P. penneri is a multiple-antibiotic-resistant (2) gram-negative organism formerly regarded as a biogroup 1 indolenegative Proteus vulgaris (3) . Chief characteristics of this species that enable its differentiation from other Proteus spp. include lack of indole production, failure to acidify esculin and salicin, failure to produce hydrogen sulfide (on triple sugar iron agar), and resistance to chloramphenicol. Like other Proteus spp., P. penneri has a cell-bound hemolytic factor, which has been shown to facilitate penetration of the organism into cultured Vero cells without any cytotoxic effects; it also has a filterable cytotoxic alpha-hemolysin rarely found in other Proteus species (10) . A highly active urease produced by P. penneri may also have a role in the establishment of an infectious process (8) .
Skin manifestations of septicemia provide an important adjunct to blood culture in the diagnosis of bacterial infec- 
